Literature DB >> 9869803

Four-eyelid sebaceous cell carcinoma following irradiation.

S Rumelt1, N R Hogan, P A Rubin, F A Jakobiec.   

Abstract

BACKGROUND: Sebaceous cell carcinoma is a distinctive tumor of the eyelid associated with a high rate of metastasis and mortality. Involvement of both upper and lower lids has been described; however, involvement of all 4 eyelids is extremely rare.
OBJECTIVE: To describe the evaluation and diagnosis of the clinicopathologic features in a 74-year-old patient with 4-eyelid sebaceous carcinoma and a history of whole face irradiation for eczema.
METHODS: Bilateral eyelid, conjunctiva, map, and fine needle biopsy of enlarged, submandibular lymph node specimens were stained with hematoxylin-eosin and oil-red-O for light microscopy and fresh-frozen sections were evaluated by electron microscopy.
RESULTS: The biopsy specimens from the eyelids and conjunctiva showed sebaceous carcinoma cells in the meibomian glands and scattered within the conjunctival epithelium. The cells were moderately well differentiated. Similar cells stained with oil-red-O were found in the submandibular lymph nodes.
CONCLUSIONS: The appearance of bilateral sebaceous carcinoma supports the concept of simultaneous occurrence of multiple primaries in specific patients, especially after radiation therapy. Patients with a history of facial irradiation and atypical eyelid lesions should be evaluated for malignant tumors such as sebaceous carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9869803     DOI: 10.1001/archopht.116.12.1670

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

2.  Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality.

Authors:  Simone Ribero; Eugenio Sportoletti Baduel; Matteo Brizio; Franco Picciotto; Emi Dika; Maria Teresa Fierro; Giuseppe Macripò; Pietro Quaglino
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.